Free Trial

Hinge Health (NYSE:HNGE) Shares Gap Down - Here's What Happened

Hinge Health logo with Medical background

Key Points

  • Hinge Health's stock price gapped down significantly from $59.03 to $52.00 before opening at $53.70, reflecting a notable market reaction.
  • Analyst ratings for Hinge Health have generally been positive, with 15 analysts rating it as a Buy and a consensus price target of $55.71.
  • Several hedge funds have recently acquired substantial new positions in Hinge Health, indicating increased institutional interest in the stock.
  • Five stocks to consider instead of Hinge Health.

Hinge Health Inc. (NYSE:HNGE - Get Free Report)'s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $59.03, but opened at $52.00. Hinge Health shares last traded at $53.70, with a volume of 820,429 shares.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Bank of America increased their price objective on shares of Hinge Health from $42.00 to $64.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Citigroup assumed coverage on shares of Hinge Health in a report on Monday, July 14th. They set an "outperform" rating for the company. William Blair assumed coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued an "outperform" rating for the company. KeyCorp boosted their price target on shares of Hinge Health from $45.00 to $60.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. Finally, Canaccord Genuity Group lifted their price objective on shares of Hinge Health from $52.00 to $61.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating and fifteen have given a Buy rating to the company. According to MarketBeat.com, Hinge Health presently has a consensus rating of "Buy" and a consensus price target of $55.71.

Get Our Latest Analysis on HNGE

Hinge Health Trading Up 2.6%

The company has a 50 day moving average of $48.33.

Institutional Trading of Hinge Health

A number of hedge funds have recently modified their holdings of the business. Montag A & Associates Inc. purchased a new position in shares of Hinge Health in the 2nd quarter worth about $41,000. SBI Securities Co. Ltd. bought a new position in shares of Hinge Health during the 2nd quarter valued at approximately $48,000. PNC Financial Services Group Inc. bought a new position in Hinge Health in the 2nd quarter worth approximately $71,000. Emerald Advisers LLC bought a new position in Hinge Health in the 2nd quarter worth approximately $108,000. Finally, Mark Sheptoff Financial Planning LLC bought a new position in Hinge Health in the 2nd quarter worth approximately $114,000.

About Hinge Health

(Get Free Report)

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

Read More

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.